The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $4.00

Today's change-0.11 -2.68%
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $4.00

Today's change-0.11 -2.68%
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.

Castlight Health Inc down (U.S.)$0.11

Castlight Health Inc closed sharply lower Friday, dropping (U.S.)$0.11 or 2.68% to (U.S.)$4.00. Over the last five days, shares have lost 4.31% and are down 6.32% for the last year to date. This security has underperformed the S&P 500 by 51.13% during the last year.

Key company metrics

  • Open(U.S.) $4.12
  • Previous close(U.S.) $4.11
  • High(U.S.) $4.12
  • Low(U.S.) $3.97
  • Bid / Ask-- / --
  • YTD % change-6.32%
  • Volume185,854
  • Average volume (10-day)191,093
  • Average volume (1-month)296,155
  • Average volume (3-month)296,006
  • 52-week range(U.S.) $2.54 to (U.S.) $7.91
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.86
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-99.45%

Castlight Health Inc has a net profit margin of -99.45%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue23212019
Total other revenue--------
Total revenue23212019
Gross profit13121110
Total cost of revenue91098
Total operating expense44404040
Selling / general / administrative25232324
Research & development10887
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-21-19-20-21
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-21-19-20-21
Income after tax-21-19-20-21
Income tax, total--------
Net income-21-19-20-21
Total adjustments to net income--------
Net income before extra. items-21-19-20-21
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-21-19-20-21
Inc. avail. to common incl. extra. items-21-19-20-21
Diluted net income-21-19-20-21
Dilution adjustment--------
Diluted weighted average shares96959494
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.20-0.21-0.23
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.22-0.20-0.21-0.23